Moreover, incidence of p53 mutation expression was related to the lower rate of survival, and the expression of HER-2/neu was related to higher probability of developing the intestinal type of stomach adenocarcinoma and ulcerative macroscopic view (Shafigh et al., 2007). The gene discussed is ERBB2; the disease is gastric adenocarcinoma.